SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-106026
Filing Date
2024-09-12
Accepted
2024-09-12 18:10:04
Documents
1
Period of Report
2024-08-25

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5823
  Complete submission text file 0000950170-24-106026.txt   7453
Mailing Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007
Business Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007 858-400-8470
Viracta Therapeutics, Inc. (Issuer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 711 HARVEST HILL ROAD CHALFONT PA 18914
Business Address
Pomerantz Roger (Reporting) CIK: 0001614936 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51531 | Film No.: 241295959